Похоже, при загрузке страницы произошла ошибка.
Наша команда получила уведомление. Если проблема сохранится, свяжитесь с нами через виджет поддерж. по email.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 31,3x - 34,6x | 33,0x |
| Selected Fwd EBIT Multiple | 3,9x - 4,4x | 4,2x |
| Fair Value | 9.459₩ - 10.628₩ | 10.044₩ |
| Upside | -18,3% - -8,2% | -13,3% |
| Benchmarks | Ticker | Full Ticker |
| TEMC CNS Co., Ltd. | A241790 | KOSDAQ:A241790 |
| Exicon Co., Ltd. | A092870 | KOSDAQ:A092870 |
| Kx Hitech Co., Ltd. | A052900 | KOSDAQ:A052900 |
| Openedges Technology, Inc. | A394280 | KOSDAQ:A394280 |
| TEMC Co., Ltd. | A425040 | KOSDAQ:A425040 |
| Keeps Biopharma Inc. | A256940 | KOSDAQ:A256940 |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| A241790 | A092870 | A052900 | A394280 | A425040 | A256940 | ||
| KOSDAQ:A241790 | KOSDAQ:A092870 | KOSDAQ:A052900 | KOSDAQ:A394280 | KOSDAQ:A425040 | KOSDAQ:A256940 | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | -14.1% | NM- | 16.8% | NM- | NM- | NM- | |
| 3Y CAGR | -28.2% | NM- | -0.6% | NM- | 15.6% | NM- | |
| Latest Twelve Months | -55.4% | -1185.4% | 8.3% | -55.1% | -6.7% | 103.4% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 13.1% | -1.1% | 7.9% | -242.0% | 11.5% | -53.7% | |
| Prior Fiscal Year | 9.5% | 1.8% | 5.2% | -81.0% | 10.5% | 3.3% | |
| Latest Fiscal Year | 3.1% | -50.3% | 6.6% | -160.6% | 6.3% | 4.9% | |
| Latest Twelve Months | 3.1% | -50.3% | 6.6% | -160.6% | 6.3% | 4.9% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 0.30x | 1.29x | 0.09x | 15.27x | 0.72x | 1.94x | |
| EV / LTM EBITDA | 4.4x | -3.1x | 0.7x | -10.4x | 6.2x | 28.0x | |
| EV / LTM EBIT | 9.8x | -2.6x | 1.3x | -9.5x | 11.4x | 39.7x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | -9.5x | 1.3x | 11.4x | ||||
| Historical EV / LTM EBIT | -100.4x | -34.4x | 39.7x | ||||
| Selected EV / LTM EBIT | 31.3x | 33.0x | 34.6x | ||||
| (x) LTM EBIT | 6,225 | 6,225 | 6,225 | ||||
| (=) Implied Enterprise Value | 194,955 | 205,216 | 215,477 | ||||
| (-) Non-shareholder Claims * | (30,726) | (30,726) | (30,726) | ||||
| (=) Equity Value | 164,229 | 174,490 | 184,751 | ||||
| (/) Shares Outstanding | 18.7 | 18.7 | 18.7 | ||||
| Implied Value Range | 8,759.51 | 9,306.80 | 9,854.08 | ||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 8,759.51 | 9,306.80 | 9,854.08 | 11,580.00 | |||
| Upside / (Downside) | -24.4% | -19.6% | -14.9% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | A241790 | A092870 | A052900 | A394280 | A425040 | A256940 | |
| Enterprise Value | 57,819 | 40,899 | 11,166 | 247,112 | 223,738 | 247,836 | |
| (+) Cash & Short Term Investments | 18,166 | 39,338 | 39,874 | 66,245 | 93,424 | 22,988 | |
| (+) Investments & Other | 408 | 52,162 | 46,217 | 0 | 8,563 | 15,110 | |
| (-) Debt | (21,287) | (7,374) | (46,569) | (18,235) | (93,246) | (55,737) | |
| (-) Other Liabilities | (4,208) | 0 | (1,723) | 0 | (95,619) | (13,087) | |
| (-) Preferred Stock | 0 | 0 | 0 | (295) | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 50,898 | 125,024 | 48,965 | 294,826 | 136,861 | 217,109 | |
| (/) Shares Outstanding | 9.7 | 12.5 | 54.3 | 21.9 | 21.2 | 18.7 | |
| Implied Stock Price | 5,240.00 | 10,000.00 | 901.00 | 13,470.00 | 6,470.00 | 11,580.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 5,240.00 | 10,000.00 | 901.00 | 13,470.00 | 6,470.00 | 11,580.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |